Progress toward cancer vaccines

Research output: Contribution to journalArticle

Abstract

The goal is to make the host immune system responsive to antigens characteristic of cancer cells, just as a classic vaccine makes the system responsive to a viral or bacterial pathogen. Several specific strategies have now reached clinical trials; by varying means, they all seek to establish context - The molecular settings in which an antigen activates T cells.

Original languageEnglish (US)
JournalHospital Practice
Volume35
Issue number12
StatePublished - Dec 15 2000

Fingerprint

Cancer Vaccines
Antigens
Immune System
Vaccines
Clinical Trials
T-Lymphocytes
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Progress toward cancer vaccines. / Jaffee, Elizabeth.

In: Hospital Practice, Vol. 35, No. 12, 15.12.2000.

Research output: Contribution to journalArticle

@article{e8bf18aa6e7a4866804bd41b92e97ddd,
title = "Progress toward cancer vaccines",
abstract = "The goal is to make the host immune system responsive to antigens characteristic of cancer cells, just as a classic vaccine makes the system responsive to a viral or bacterial pathogen. Several specific strategies have now reached clinical trials; by varying means, they all seek to establish context - The molecular settings in which an antigen activates T cells.",
author = "Elizabeth Jaffee",
year = "2000",
month = "12",
day = "15",
language = "English (US)",
volume = "35",
journal = "Hospital practice (1995)",
issn = "2154-8331",
publisher = "Taylor and Francis Ltd.",
number = "12",

}

TY - JOUR

T1 - Progress toward cancer vaccines

AU - Jaffee, Elizabeth

PY - 2000/12/15

Y1 - 2000/12/15

N2 - The goal is to make the host immune system responsive to antigens characteristic of cancer cells, just as a classic vaccine makes the system responsive to a viral or bacterial pathogen. Several specific strategies have now reached clinical trials; by varying means, they all seek to establish context - The molecular settings in which an antigen activates T cells.

AB - The goal is to make the host immune system responsive to antigens characteristic of cancer cells, just as a classic vaccine makes the system responsive to a viral or bacterial pathogen. Several specific strategies have now reached clinical trials; by varying means, they all seek to establish context - The molecular settings in which an antigen activates T cells.

UR - http://www.scopus.com/inward/record.url?scp=0034670637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034670637&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034670637

VL - 35

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 12

ER -